Morphological classification of glioblastomas;Classification morphologique des glioblastomes

Neurochirurgie

Volumn 56, Issue 6, 2010, Pages 459-463

  Figarella Branger, D ^a,b,c   Bouvier, C ^a,b,c   Moroch, J ^d   Michalak, S ^d   Burel Vandenbos, F ^e,f  

^a University of the Mediterranean Aix Marseille II   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c TIMONE HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e PASTEUR HOSPITAL   (France)

^f INSERM   (France)

Author keywords

Glioblastoma; Histology; IDH1; Immunohistochemical markers; Internexin a

Indexed keywords

ALPHA INTERNEXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; ISOCITRATE DEHYDROGENASE 1; KI 67 ANTIGEN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN P53; TUMOR MARKER; BIOLOGICAL MARKER;

ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; DIAGNOSTIC VALUE; GIANT CELL GLIOBLASTOMA; GIANT CELL TUMOR; GLIOBLASTOMA; GLIOSARCOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIPIDOSIS; MORPHOLOGY; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; SMALL CELL CARCINOMA; SMALL CELL GLIOBLASTOMA; TUMOR DIFFERENTIATION; WORLD HEALTH ORGANIZATION; BRAIN TUMOR; CHEMISTRY; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; PATHOLOGY; PROGNOSIS;

BIOLOGICAL MARKERS; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; GLIOBLASTOMA; HUMANS; PROGNOSIS;

EID: 79953303677     PISSN: 00283770     EISSN: 17730619     Source Type: Journal    
DOI: 10.1016/j.neuchi.2010.07.014     Document Type: Article

References (22)

1. Biernat W., Aguzzi A., Sure U., Grant J.W., Kleihues P., Hegi M.E. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J. Neuropathol. Exp. Neurol. 1995, 54(5):651-656.
2. Bouvier C., Bartoli C., Aguirre-Cruz L., Virard I., Colin C., Fernandez C., et al. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells. J. Neurosurg. 2003, 99(2):344-350.
3. Colin C., Virard I., Baeza N., Tchoghandjian A., Fernandez C., Bouvier C., et al. Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis. Neuropathol. Appl. Neurobiol. 2007, 33(4):431-439.
4. Capper D., Weibert S., Balss J., Habel A., Meyer Jäger D., et al. Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol. 2009, [epub ahead of print].
5. Coulibaly, B., Nanni, I., Quilichini, B., Gaudart, J., Metellus, P., Fina, F., et al., 2010. EGFR in glioblastomas: correlation between gene copy number and protein expression and impact on prognosis. Hum. Pathol. 41 (6), 15-23.
6. Ducray F., Criniere E., Idbaih A., Mokhtari K., Marie Y., Paris S., et al. Alpha-internexin expression identifies 1p19q codeleted gliomas. Neurology 2009, 72(2):156-161.
7. Feigin I., Allen L.B., Lipkin L., Gross S.W. The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation. Cancer 1958, 11(2):264-277.
8. He J., Mokhtari K., Sanson M., Marie Y., Kujas M., Huguet S., et al. Glioblastomas with an oligodendroglial component: a pathological and molecular study. J. Neuropathol. Exp. Neurol. 2001, 60(9):863-871.
9. Hirsch F.R., Varella-Garcia M., Bunn, Di Maria M.V., Veve R., Bremmes R.M., et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J. Clin. Oncol. 2003, 21(20):3798-3807.
10. Kelly P.J., Daumas-Duport C., Scheithauer B.W., Kall B.A., Kispert D.B. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin. Proc. 1987, 62(6):450-459.
11. Kepes J.J., Rubinstein L.J. Malignant gliomas with heavily lipidized (foamy) tumor cells: a report of three cases with immunoperoxidase study. Cancer 1981, 47(10):2451-2459.
12. Kleihues P., Aldape K.D., Brat D.J., Biernat W., Bigner D.D., et al. Glioblastoma. WHO classification of tumours of the central nervous system 2007, 33-49. IARC Press, Lyon.
13. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114(2):97-109.
14. Martinez-Diaz H., Kleinschmidt-DeMasters B.K., Powell S.Z., Yachnis A.T. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch. Pathol. Lab. Med. 2003, 127(9):1187-1191.
15. Miller C.R., Dunham C.P., Scheithauer B.W., Perry A. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. J. Clin. Oncol. 2006, 24(34):5419-5426.
16. Peraud A., Watanabe K., Schwechheimer K., Yonekawa Y., Kleihues P., Ohgaki H. Genetic profile of the giant cell glioblastoma. Lab. Invest. 1999, 79(2):123-129.
17. Perry A., Aldape K.D., George D.H., Burger P.C. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer 2004, 101(10):2318-2326.
18. Phillips H.S., Kharbanda S., Chen R., Forrest W.F., Soriano R.H., Wu T.D., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9(3):157-173.
19. Reifenberger J., Reifenberger G., Ichimura K., Schmidt E.E., Wechsler W., Collins V.P. Epidermal growth factor receptor expression in oligodendroglial tumors. Am. J. Pathol. 1996, 149(1):29-35.
20. Reis R.M., Konu-Lebleblicioglu D., Lopes J.M., Kleihues P., Ohgaki H. Genetic profile of gliosarcomas. Am. J. Pathol. 2000, 156(2):425-432.
21. Smith J.S., Tachibana I., Passe S.M., Huntley B.K., Borell T.J., Iturria N., et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J. Natl. Cancer Inst. 2001, 93(16):1246-1256.
22. Varlet P., Soni D., Miquel C., Roux F.X., Meder J.F., Chneiweiss H., et al. New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases. Neurosurgery 2004, 55(6):1377-1391. [discussion 1391-2].